Gdnf Haploinsufficiency Causes Hirschsprung-like Intestinal Obstruction and Early-onset Lethality in Mice
Overview
Affiliations
Hirschsprung disease (HSCR) is a common congenital disorder that results in intestinal obstruction and lethality, as a result of defective innervation of the gastrointestinal (GI) tract. Despite its congenital origin, the molecular etiology of HSCR remains elusive for >70% of patients. Although mutations in the c-RET receptor gene are frequently detected in patients with HSCR, mutations in the gene encoding its ligand (glial cell line-derived neurotrophic factor [GDNF]), are rarely found. In an effort to establish a possible link between human HSCR and mutations affecting the Gdnf locus, we studied a large population of mice heterozygous for a Gdnf null mutation. This Gdnf(+/-) mutant cohort recapitulates complex features characteristic of HSCR, including dominant inheritance, incomplete penetrance, and variable severity of symptoms. The lack of one functioning Gdnf allele causes a spectrum of defects in gastrointestinal motility and predisposes the mutant mice to HSCR-like phenotypes. As many as one in five Gdnf(+/-) mutant mice die shortly after birth. Using a transgenic marking strategy, we identified hypoganglionosis of the gastrointestinal tract as a developmental defect that renders the mutant mice susceptible to clinical symptoms of HSCR. Our findings offer a plausible way to link an array of seemingly disparate features characteristic of a complex disease to a much more narrowly defined genetic cause. These findings may have general implications for the genetic analysis of cause and effect in complex human diseases.
Causes and consequences: development and pathophysiology of Hirschsprung disease.
Burns A, Goldstein A World J Pediatr Surg. 2024; 7(4):e000903.
PMID: 39600627 PMC: 11590806. DOI: 10.1136/wjps-2024-000903.
Cutting-edge regenerative therapy for Hirschsprung disease and its allied disorders.
Yoshimaru K, Matsuura T, Uchida Y, Sonoda S, Maeda S, Kajihara K Surg Today. 2023; 54(9):977-994.
PMID: 37668735 DOI: 10.1007/s00595-023-02741-6.
Sunardi M, Ito K, Sato Y, Uesaka T, Iwasaki M, Enomoto H Cell Mol Gastroenterol Hepatol. 2022; 15(6):1505-1524.
PMID: 36521661 PMC: 10242352. DOI: 10.1016/j.jcmgh.2022.12.003.
Modification of Neurogenic Colonic Motor Behaviours by Chemogenetic Ablation of Calretinin Neurons.
Feng J, Hibberd T, Luo J, Yang P, Xie Z, Travis L Front Cell Neurosci. 2022; 16:799717.
PMID: 35317196 PMC: 8934436. DOI: 10.3389/fncel.2022.799717.
Cham T, Ibtisham F, Fayaz M, Honaramooz A Cells. 2021; 10(7).
PMID: 34359871 PMC: 8305979. DOI: 10.3390/cells10071696.